EP2968155
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.3.2014EP published:
3.3.2021EP application number:
14726410.5
EPO information:
European Patent Register
Max expiry date:
11.3.2034
Title:
TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS
Timeline
Today
12.3.2014EP application
3.3.2021EP Publication
Owner
Name:
Pfizer Inc.Address:
235 East 42nd Street, New York, NY 10017, US
Inventor
Name:
HERBIG, Scott MaxAddress:
East Lyme, Connecticut 06333, US
Name:
KRISHNASWAMI, SriramAddress:
East Lyme, Connecticut 06333, US
Name:
KUSHNER IV, JosephAddress:
Bradford, Rhode Island 02808, US
Name:
LAMBA, ManishaAddress:
Waterford, Connecticut 06385, US
Name:
STOCK, Thomas C.Address:
Chester Springs, Pennsylvania 19425, US
Priority
Number:
201361802479 PDate:
16.3.2013Country:
US
Number:
201361864059 PDate:
9.8.2013Country:
US
Number:
201461934428 PDate:
31.1.2014Country:
US
Classification
Categories:
A61K 9/28, A61K 9/48, A61K 31/519, A61P 1/04, A61P 17/06, A61P 19/02, A61P 37/06